Comparison between Shriram Properties IPO and Supriya Lifescience IPO.
Shriram Properties IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Shriram Properties IPO is up to ₹600.04 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of Shriram Properties IPO is ₹118.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
| Shriram Properties IPO | Supriya Lifescience IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹113.00 per share | ₹265.00 per share |
| Issue Price (Upper) | ₹118.00 per share | ₹274.00 per share |
| Issue Price (Final) | ₹118.00 per share | ₹274.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹11.00 per share | |
| Market Lot Size | 125 shares | 54 shares |
| Fresh Issue Size | 2,12,12,576 shares | 72,99,270 shares |
| Fresh Issue Size (Amount) | up to ₹250.20 Cr | up to ₹200.00 Cr |
| OFS Issue Size | 2,96,61,016 shares | 1,82,48,175 shares |
| OFS Issue Size (Amount) | up to ₹349.84 Cr | up to ₹500.00 Cr |
| Issue Size Total | 5,08,73,592 shares | 2,55,47,445 shares |
| Issue Size Total (Amount) | up to ₹600.04 Cr | up to ₹700.00 Cr |
Shriram Properties IPO opens on Dec 08, 2021, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of Shriram Properties IPO and Supriya Lifescience IPO is Dec 10, 2021, and Dec 20, 2021, respectively.
| Shriram Properties IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Bid Date | Dec 07, 2021 | Dec 15, 2021 |
| Issue Open | Dec 08, 2021 | Dec 16, 2021 |
| Issue Close | Dec 10, 2021 | Dec 20, 2021 |
| Basis Of Allotment (Tentative) | Dec 15, 2021 | Dec 23, 2021 |
| Initiation of Refunds (Tentative) | Dec 16, 2021 | Dec 24, 2021 |
| Credit of Share (Tentative) | Dec 17, 2021 | Dec 27, 2021 |
| Listing date (Tentative) | Dec 20, 2021 | Dec 28, 2021 |
| Anchor Lockin End date 1 | Jan 14, 2022 | Jan 22, 2022 |
| Anchor Lockin End date 2 | Mar 15, 2022 | Mar 23, 2022 |
Shriram Properties IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .
| Shriram Properties IPO | Supriya Lifescience IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 32 | 99.98 | ||||
| Promoter Shareholding (Post-Issue) | 28 | 68.24 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹2001.56 Cr. | ₹700.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Shriram Properties IPO Retail Individual Investors (RII) are offered 50,59,321 shares while in Supriya Lifescience IPO retail investors are offered 50,59,321 shares. Qualified Institutional Buyers (QIB) are offered 1,51,77,967 shares in Shriram Properties IPO and 76,64,234 shares in Supriya Lifescience IPO.
| Shriram Properties IPO | Supriya Lifescience IPO | |
|---|---|---|
| Anchor Investor Reservation | 2,27,66,949 shares | 1,14,96,351 shares |
| Market Maker Reservation | ||
| QIB | 1,51,77,967 shares | 76,64,234 shares |
| NII | 75,88,982 shares | 38,32,116 shares |
| RII | 50,59,321 shares | 25,54,744 shares |
| Employee | 2,80,373 shares | |
| Others | ||
| Total | 5,08,73,592 shares | 2,55,47,445 shares |
Shriram Properties IPO subscribed 4.60x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
| Shriram Properties IPO | Supriya Lifescience IPO | |
|---|---|---|
| QIB (times) | 1.85x | 31.83x |
| NII (times) | 4.82x | 161.22x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 12.72x | 56.01x |
| Employee (times) | 1.25x | |
| Other (times) | ||
| Total (times) | 4.60x | 71.51x |
